|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Xilio Therapeutics (NASDAQ: XLO) through any online brokerage.
The latest price target for Xilio Therapeutics (NASDAQ: XLO) was reported by HC Wainwright & Co. on January 10, 2022. The analyst firm set a price target for 36.00 expecting XLO to rise to within 12 months (a possible 164.32% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $13.62 last updated Fri Jan 21 2022 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Xilio Therapeutics.
Xilio Therapeutics’s $Q4 earnings are confirmed for after-market on February 19, 2022.
There is no upcoming split for Xilio Therapeutics.
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.